dEEGtal Insight
PrivateLast Round
Grant
Sep 23, 2025
Total Funding Raised
$1.85M
Company Overview
dEEGtal Insight operates in Healthcare & Life Sciences and is based in Geneva. Its latest recorded funding round was a Grant round in September 2025.
dEEGtal Insight is a medical technology company that provides AI-powered software to enhance and accelerate the diagnosis of epilepsy.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Government Contracts, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
dEEGtal Insight Comparables
Compare dEEGtal Insight with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Piramidal | 81% | |
| Persyst Development Corporation | 74% | |
| AIT Austrian Institute of Technology | 74% |
For institutional investors. Book with your work email.
dEEGtal Insight Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 23, 2025 | ||||
| Seed | Dec 13, 2024 | ||||
| Grant | Aug 26, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
dEEGtal Insight Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Wyss Center for Bio and Neuroengineering | Seed |
| Innosuisse | Grant |
| Venture Kick | Grant, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 23, 2025
$704K grant received from Innosuisse.
- Dec 13, 2024
$1.1M round led by Wyss Center for Bio and Neuroengineering
For institutional investors. Book with your work email.
dEEGtal Insight Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about dEEGtal Insight's valuation, stock price, and market status.
Is dEEGtal Insight a public or private company?
dEEGtal Insight is a private company.
What is the current stock price of dEEGtal Insight?
dEEGtal Insight is a private company, so its shares have no public market price. Caplight tracks dEEGtal Insight's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is dEEGtal Insight worth (valuation)?
Valuation information for dEEGtal Insight is not publicly available.
Can I buy dEEGtal Insight stock?
dEEGtal Insight shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was dEEGtal Insight's last funding round?
dEEGtal Insight's most recent funding round was Grant on September 23, 2025.
Who are the main investors in dEEGtal Insight?
Key investors in dEEGtal Insight include Wyss Center for Bio and Neuroengineering.
Will dEEGtal Insight IPO soon?
No public IPO plans have been announced for dEEGtal Insight.
How can I track dEEGtal Insight secondary market activity?
Caplight tracks bids, offers, and trades in dEEGtal Insight's shares on secondary markets.